Skip to content
IDEXX LABORATORIES INC /DE (IDXX) Insider Trading
Home / Companies / IDXX IDX
IDEXX LABORATORIES INC /DE (IDXX) S&P 500 NASDAQ-100 XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Net insider buying (90d)
Latest IDXX Insider Trades
About IDEXX LABORATORIES INC /DE (IDXX) Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Headquarters WESTBROOK, ME
Employees 11,000
Listed 1991
Exchange XNAS https://www.idexx.com SEC filings for IDXX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Grant or award 1 49 Option exercise 4 1,808 Tax withholding / forfeiture 2 370
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
IDXX Insider Transactions (Form 4) 135 59 Form 4 filings on record, the earliest from Nov 29, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 20, 2026 AE Andrew Emerson - Officer Option exercise Common Stock 265
Recent IDXX Form 8-K Filings 4
Recent IDXX Form 144 Notices of Proposed Sale 1 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice May 20, 2026 - - - - View on EDGAR
IDXX Insider Trading - FAQ
What is the latest insider trade for IDXX? IDEXX LABORATORIES INC /DE (IDXX) had 3 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for IDXX runs to 59 Form 4 filings, the earliest from 2024-11-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying IDXX stock? No insider purchases of IDXX were filed in the last 90 days.
How many insiders are selling IDXX stock? No insider sales of IDXX were filed in the last 90 days. 59 sales are on record for this company.
Where can I see IDXX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks IDXX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow IDXX insider buys? Create a free InsiderAlpha account and press Watch on this page to add IDXX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track IDXX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $43.72B
P/E ratio 39.00
Dividend yield -
Average volume 639.1K
52 week high $769.98
52 week low $518.55
Today's high $556.01
Today's low $545.48
Open $547.81
Volume 341.0K
Previous close $545.08
Shares outstanding 78.78M Market cap
$43.72B
11,000 employees
Most-Active IDXX Insiders - Last 90 Days 10 Aug 20, 2026 AE Andrew Emerson - Officer Tax withholding / forfeiture Common Stock 86 $0.00 -
Aug 20, 2026 AE Andrew Emerson - Officer Option exercise Incentive Stock Option (right-to-buy) 265 - -
Jul 30, 2026 JH Joseph L. Hooley - Director Grant or award Common Stock 49 $558.80 $27K
Jun 1, 2026 GF George Fennell - Officer Option exercise Common Stock 639 $0.00 -
Jun 1, 2026 GF George Fennell - Officer Tax withholding / forfeiture Common Stock 284 $566.79 $161K
Jun 1, 2026 GF George Fennell - Officer Option exercise Restricted Stock Unit 639 - -
May 12, 2026 SV Sophie V. Vandebroek - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 SS Sam Samad - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 SS Sam Samad - Director Grant or award Deferred Stock Unit 234 $0.00 -
May 12, 2026 KP Karen Peacock - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 KP Karen Peacock - Director Grant or award Deferred Stock Unit 234 $0.00 -
May 12, 2026 LK Lawrence D. Kingsley - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 LK Lawrence D. Kingsley - Director Grant or award Non-Qualified Stock Option (right-to-buy) 168 $0.00 -
May 12, 2026 DJ Daniel M. Junius - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 DJ Daniel M. Junius - Director Grant or award Restricted Stock Unit 234 $0.00 -
May 12, 2026 JH Joseph L. Hooley - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 JH Joseph L. Hooley - Director Grant or award Deferred Stock Unit 234 $0.00 -
May 12, 2026 SE Stuart Essig - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 SE Stuart Essig - Director Grant or award Restricted Stock Unit 234 $0.00 -
May 12, 2026 BC Bruce L. Claflin - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 12, 2026 BC Bruce L. Claflin - Director Grant or award Deferred Stock Unit 234 $0.00 -
May 12, 2026 IB Irene Chang Britt - Director Grant or award Non-Qualified Stock Option (right-to-buy) 525 $0.00 -
May 7, 2026 MS M. Anne Szostak - Director Option exercise Common Stock 257 $0.00 -
May 7, 2026 MS M. Anne Szostak - Director Option exercise Restricted Stock Unit 257 - -
May 7, 2026 KP Karen Peacock - Director Option exercise Common Stock 101 $0.00 -
May 7, 2026 KP Karen Peacock - Director Option exercise Restricted Stock Unit 101 - -
May 7, 2026 DJ Daniel M. Junius - Director Option exercise Restricted Stock Unit 257 - -
May 7, 2026 JH Joseph L. Hooley - Director Option exercise Restricted Stock Unit 158 - -
Apr 30, 2026 JH Joseph L. Hooley - Director Grant or award Common Stock 43 $560.80 $24K
Mar 3, 2026 SU Sharon E. Underberg - Officer Option exercise Incentive Stock Option (right-to-buy) 197 - -
Mar 3, 2026 NH Nimrata Hunt - Officer Open-market sale Common Stock 1,758 $634.57 $1.12M
Feb 12, 2026 ME Michael G. Erickson - Officer Grant or award Non-Qualified Stock Option (right-to-buy) 13,667 $0.00 -
Feb 12, 2026 ME Michael G. Erickson - Officer Grant or award Incentive Stock Option (right-to-buy) 162 $0.00 -
Feb 26, 2026 JM Jonathan Jay Mazelsky - Officer Option exercise Non-Qualified Stock Option (right-to-buy) 23,326 $0.00 -
Feb 27, 2026 JM Jonathan Jay Mazelsky - Officer Option exercise Incentive Stock Option (right-to-buy) 197 $0.00 -
Feb 26, 2026 NH Nimrata Hunt - Officer Open-market sale Common Stock 2,693 $661.54 $1.78M
Feb 19, 2026 ME Michael G. Erickson - Officer Option exercise Incentive Stock Option (right-to-buy) 817 $0.00 -
Feb 17, 2026 ME Michael G. Erickson - Officer Option exercise Non-Qualified Stock Option (right-to-buy) 1,191 $0.00 -
Feb 17, 2026 ME Michael G. Erickson - Officer Option exercise Non-Qualified Stock Option (right-to-buy) 4,180 $0.00 -
Feb 19, 2026 ME Michael G. Erickson - Officer Option exercise Incentive Stock Option (right-to-buy) 719 $0.00 -
Feb 19, 2026 ME Michael G. Erickson - Officer Option exercise Incentive Stock Option (right-to-buy) 483 $0.00 -
Feb 19, 2026 ME Michael G. Erickson - Officer Option exercise Incentive Stock Option (right-to-buy) 183 $0.00 -
Feb 19, 2026 ME Michael G. Erickson - Officer Option exercise Incentive Stock Option (right-to-buy) 197 $0.00 -
Feb 17, 2026 SV Sophie V. Vandebroek - Director Option exercise Non-Qualified Stock Option (right-to-buy) 945 - -
Feb 14, 2026 SU Sharon E. Underberg - Officer Tax withholding / forfeiture Common Stock 251 $629.35 $158K
Feb 12, 2026 SU Sharon E. Underberg - Officer Grant or award Non-Qualified Stock Option (right-to-buy) 3,738 $0.00 -
Feb 12, 2026 SU Sharon E. Underberg - Officer Grant or award Incentive Stock Option (right-to-buy) 162 $0.00 -
Feb 12, 2026 MS Martin Alexander Smith - Officer Grant or award Non-Qualified Stock Option (right-to-buy) 5,361 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Common Stock 169 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Common Stock 301 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Common Stock 367 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Common Stock 1,005 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Common Stock 117 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Tax withholding / forfeiture Common Stock 876 $629.35 $551K
Feb 12, 2026 MS Michael Schreck - Officer Grant or award Non-Qualified Stock Option (right-to-buy) 4,625 $0.00 -
Feb 12, 2026 MS Michael Schreck - Officer Grant or award Incentive Stock Option (right-to-buy) 162 $0.00 -
Feb 12, 2026 MS Michael Schreck - Officer Grant or award Restricted Stock Unit 1,094 $0.00 -
Feb 12, 2026 MS Michael Schreck - Officer Grant or award Restricted Stock Unit 1,620 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Restricted Stock Unit 117 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Restricted Stock Unit 169 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Restricted Stock Unit 301 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Restricted Stock Unit 367 $0.00 -
Feb 14, 2026 MS Michael Schreck - Officer Option exercise Restricted Stock Unit 1,005 $0.00 -
$IMDX
Insight Molecular Diagnostics Inc.
Jonathan Jay Mazelsky - OfficerOpen-market sale$976K
